Back to LOOMIS SAYLES & CO L PREGN
REGNShowing 8 of 30 quarters
Position history for LOOMIS SAYLES & CO L P's holdings in REGENERON PHARMACEUTICALS
LOOMIS SAYLES & CO L P holds 1.9M shares of REGN (REGENERON PHARMACEUTICALS), worth $1.5B as of 2026-Q1. The position was decreased (-1.1% shares). REGN represents 2.0% of LOOMIS SAYLES & CO L P's portfolio.
Current Value
$1.5B
Current Shares
1.9M
Total Value Change
+$198.6M
Total Shares Change
+695,454
Quarter-by-Quarter History
Other major holders of REGN: VANGUARD GROUP INC, BlackRock Finance, Inc.